Global Cannabinoid Derived Pharmaceutical Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Cannabinoid Derived Pharmaceutical market size was valued at USD 909.6 million in 2022 and is forecast to a readjusted size of USD 1994.1 million by 2029 with a CAGR of 11.9% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Cannabinoid Derived Pharmaceutical market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cannabinoid Derived Pharmaceutical market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cannabinoid Derived Pharmaceutical market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cannabinoid Derived Pharmaceutical market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cannabinoid Derived Pharmaceutical market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cannabinoid Derived Pharmaceutical
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cannabinoid Derived Pharmaceutical market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cara Therapeutics Inc, Arena Pharmaceuticals, Cannabics Pharmaceuticals Inc, Echo Pharmaceuticals and Gw Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cannabinoid Derived Pharmaceutical market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cannabinoid Receptor Type 1 (CB1)
Cannabinoid Receptor Type 2 (CB2)
Others
Market segment by Application
Epilepsy
Migraine
Multiple Sclerosis
Others
Major players covered
Cara Therapeutics Inc
Arena Pharmaceuticals
Cannabics Pharmaceuticals Inc
Echo Pharmaceuticals
Gw Pharmaceuticals
Inmed Pharmaceuticals
Insys Therapeutics Inc
Larapharm
Mgc Pharmaceuticals Ltd
One World Cannabis
Orpheus Medica
Receptor Life Sciences
Respirerx Pharmaceuticals
Tetra Bio-Pharma
Cardiol Therapeutics
United Cannabis Corporation
Zynerba Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cannabinoid Derived Pharmaceutical product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cannabinoid Derived Pharmaceutical, with price, sales, revenue and global market share of Cannabinoid Derived Pharmaceutical from 2018 to 2023.
Chapter 3, the Cannabinoid Derived Pharmaceutical competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cannabinoid Derived Pharmaceutical breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cannabinoid Derived Pharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cannabinoid Derived Pharmaceutical.
Chapter 14 and 15, to describe Cannabinoid Derived Pharmaceutical sales channel, distributors, customers, research findings and conclusion.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook